| Number of Journals | 8 |
| Number of Issues | 52 |
| Number of Articles | 384 |
| Article View | 120,838 |
| PDF Download | 88,451 |
COVID-19 in a Depressed Patient with Generalized Urticaria | ||
| Advances in Pharmacology and Therapeutics Journal | ||
| Volume 2, Issue 1 - Serial Number 3, September 2022, Pages 4-7 PDF (219.38 K) | ||
| Document Type: Case study | ||
| DOI: 10.18502/aptj.v2i1.10650 | ||
| Authors | ||
| Reza Bidaki; Fatemeh Zarnegar; Fatemeh Saghafi* | ||
| Abstract | ||
| Health concerns, changes in lifestyle, job losses, economic hardships, and the death of family members during the Covid-19 pandemic have led to depressive disorders. Here, a 39-year-old man referred to a psychiatric clinic with the complication of depressed mood, which was exacerbated by stress, anxiety, restlessness, and insomnia. In addition, he was referred to a cardiologist and dermatologist because of uncontrolled tachycardia and urticaria. After detailed examination, the final diagnosis was COVID-19, along with anxiety disorder and dermatological diseases. Since the Coronavirus disease (COVID-19) can cause stress and psychological problems, it can disrupt the patient's healing process if ignored. On the other hand, there seems to be a strong association between psychiatric illnesses with COVID-19 and urticaria that can be investigated. | ||
| Keywords | ||
| COVID-19; Depression; Psychiatric Disorder Urticaria | ||
|
Statistics Article View: 148 PDF Download: 161 |
||